[go: up one dir, main page]

CA2393614A1 - Antibacterial clarithromycin compositions and processes for making the same - Google Patents

Antibacterial clarithromycin compositions and processes for making the same Download PDF

Info

Publication number
CA2393614A1
CA2393614A1 CA002393614A CA2393614A CA2393614A1 CA 2393614 A1 CA2393614 A1 CA 2393614A1 CA 002393614 A CA002393614 A CA 002393614A CA 2393614 A CA2393614 A CA 2393614A CA 2393614 A1 CA2393614 A1 CA 2393614A1
Authority
CA
Canada
Prior art keywords
making
same
antibacterial
processes
clarithromycin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002393614A
Other languages
French (fr)
Other versions
CA2393614C (en
Inventor
Azita Saleki-Gerhardt
Rick Rafeldt
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BGP Products Operations GmbH
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=4171189&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CA2393614(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Individual filed Critical Individual
Priority to CA2433962A priority Critical patent/CA2433962C/en
Priority to CA002393614A priority patent/CA2393614C/en
Publication of CA2393614A1 publication Critical patent/CA2393614A1/en
Application granted granted Critical
Publication of CA2393614C publication Critical patent/CA2393614C/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/717—Celluloses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Biophysics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Abridged clarithromycin antibacterial compositions and methods for making the same are disclosed -15-
CA002393614A 2002-07-19 2002-07-19 Antibacterial clarithromycin compositions and processes for making the same Expired - Lifetime CA2393614C (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
CA2433962A CA2433962C (en) 2002-07-19 2002-07-19 Antibacterial clarithromycin compositions and processes for making the same
CA002393614A CA2393614C (en) 2002-07-19 2002-07-19 Antibacterial clarithromycin compositions and processes for making the same

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA002393614A CA2393614C (en) 2002-07-19 2002-07-19 Antibacterial clarithromycin compositions and processes for making the same

Related Child Applications (1)

Application Number Title Priority Date Filing Date
CA2433962A Division CA2433962C (en) 2002-07-19 2002-07-19 Antibacterial clarithromycin compositions and processes for making the same

Publications (2)

Publication Number Publication Date
CA2393614A1 true CA2393614A1 (en) 2002-10-28
CA2393614C CA2393614C (en) 2003-09-30

Family

ID=4171189

Family Applications (2)

Application Number Title Priority Date Filing Date
CA2433962A Expired - Lifetime CA2433962C (en) 2002-07-19 2002-07-19 Antibacterial clarithromycin compositions and processes for making the same
CA002393614A Expired - Lifetime CA2393614C (en) 2002-07-19 2002-07-19 Antibacterial clarithromycin compositions and processes for making the same

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CA2433962A Expired - Lifetime CA2433962C (en) 2002-07-19 2002-07-19 Antibacterial clarithromycin compositions and processes for making the same

Country Status (1)

Country Link
CA (2) CA2433962C (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004006917A1 (en) * 2002-07-16 2004-01-22 Ranbaxy Laboratories Limited Dispersible tablets for oral administration
RU2268051C2 (en) * 2003-12-15 2006-01-20 Закрытое акционерное общество "Фармацевтическое предприятие "Оболенское" Medicinal formulation possessing bacteriostatic effect and method for its preparing
WO2012060785A1 (en) * 2010-11-05 2012-05-10 Mahmut Bilgic Production method for tablets comprising cephalosporin
WO2012060793A3 (en) * 2010-11-05 2012-06-28 Mahmut Bilgic Process for the preparation of cefdinir formulations

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004006917A1 (en) * 2002-07-16 2004-01-22 Ranbaxy Laboratories Limited Dispersible tablets for oral administration
RU2268051C2 (en) * 2003-12-15 2006-01-20 Закрытое акционерное общество "Фармацевтическое предприятие "Оболенское" Medicinal formulation possessing bacteriostatic effect and method for its preparing
WO2012060785A1 (en) * 2010-11-05 2012-05-10 Mahmut Bilgic Production method for tablets comprising cephalosporin
WO2012060793A3 (en) * 2010-11-05 2012-06-28 Mahmut Bilgic Process for the preparation of cefdinir formulations
WO2012060789A3 (en) * 2010-11-05 2012-06-28 Mahmut Bilgic Production method for cefdinir formulations

Also Published As

Publication number Publication date
CA2433962A1 (en) 2002-10-28
CA2393614C (en) 2003-09-30
CA2433962C (en) 2012-10-30

Similar Documents

Publication Publication Date Title
AU2002334307A1 (en) Novel lna compositions and uses thereof
AU2002344488A1 (en) Air conditioner
AU2002324347A1 (en) Air conditioner
AU2002308050A1 (en) Milieux de detection specific de staphylococcus aureus
AU2002330393A1 (en) Air conditioner
AU2002332260A1 (en) Air conditioner
AU2002246337A1 (en) Air conditioner
AU2002314573A1 (en) Air conditioner
AU2002314574A1 (en) Air conditioner
AU2002309317A1 (en) Air conditioner
AU2001271052A1 (en) Antibacterial composition
AU2002236276A1 (en) Air Conditioner
CA2393614A1 (en) Antibacterial clarithromycin compositions and processes for making the same
AU2002332328A1 (en) Air conditioner
AUPR548801A0 (en) Room conditioning
AU2002320942A1 (en) Flame-proofing agent and means for the production thereof
AU2002311654A1 (en) Air conditioner
AU2002354567A1 (en) Not given
AU2002342944A1 (en) Fiberboards and processes for the preparation thereof
AU2002238411A1 (en) Screwdriver
AU3315302A (en) Point contacts for semiconductors and the production thereof
AU2002303498A1 (en) Antibiotics aa-896
AU2003227216A1 (en) Novel polyesterified block copolymer and process for producing the same
AU2002250433A1 (en) Dry fertilizer compositions and method for making the same
AU2002338091B2 (en) Air conditioner

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry

Effective date: 20220719

MKEX Expiry

Effective date: 20220719